1. Home
  2. LBRX vs WDH Comparison

LBRX vs WDH Comparison

Compare LBRX & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$23.91

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Logo Waterdrop Inc. (each representing the right to receive 10)

WDH

Waterdrop Inc. (each representing the right to receive 10)

N/A

Current Price

$1.76

Market Cap

654.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LBRX
WDH
Founded
2015
2016
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
602.6M
654.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LBRX
WDH
Price
$23.91
$1.76
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$49.00
N/A
AVG Volume (30 Days)
181.2K
263.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
3.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.60
P/E Ratio
N/A
$9.00
Revenue Growth
N/A
N/A
52 Week Low
$13.40
$1.16
52 Week High
$25.60
$2.18

Technical Indicators

Market Signals
Indicator
LBRX
WDH
Relative Strength Index (RSI) 52.85 46.93
Support Level $22.34 $1.75
Resistance Level $24.70 $1.90
Average True Range (ATR) 1.26 0.06
MACD -0.14 -0.00
Stochastic Oscillator 51.76 26.95

Price Performance

Historical Comparison
LBRX
WDH

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

About WDH Waterdrop Inc. (each representing the right to receive 10)

Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.

Share on Social Networks: